Live Breaking News & Updates on அதிர்ஷ்டம் வணிக|Page 6

Stay updated with breaking news from அதிர்ஷ்டம் வணிக. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel Anti-Cancer Drugs Permeate the Marketplace


Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with cancer in the United States in 2020 alone. However, the oncology and cancer drug market is expected to grow largely due to the surge in cancer research, the rise in the geriatric population worldwide, as well as the increase in collaboration between pharmaceutical companies. Moreover, the high market growth potential in developing nations, a rise in the number of pipeline products, and an upsurge in demand for personalized medicines are expected to create new opportunities for market players. And, according to data published by Market Industry Reports, the cancer therapeutics market was estimated to be valued at over USD 140 Billion in 2019 and is anticipated to grow at a CAGR of ~7.7% from 2019 to 2030. Sunshine Biop ....

United States , Melissa Aucoin , Anna Berkenblit , Steve Slilaty , National Cancer Institute , American Society Of Clinical Oncology , Sunshine Biopharma Inc , Immunogen Inc , Company Interviews , Trillium Therapeutics Inc , Drug Administration , National Ovarian Cancer Coalition , Yuhan Corporation , Verastem Inc , Immuneoncia Therapeutics Inc , Sorrento Therapeutics Inc , Market Industry Reports , Trillium Therapeutics , Sorrento Therapeutics , Fortune Business , Sunshine Biopharma , Breakthrough Therapy , National Ovarian Cancer , Clinical Oncology , Virtual Annual Meeting , Senior Vice President ,

China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China


China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China
Source:
Jan Antonin Kolar/Unsplash
May 24, 2021
TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round led by Sealand Innovation, while TAOS Data has secured $47 million in a Series B round led by Matrix Partners China.
TYK Medicines bags nearly $62m Series B+
Chinese biopharmaceutical firm TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round of financing led by Sealand Innovation, a 17.6 billion yuan ($2.7 billion) fund owned by Sealand Securities, according to a company statement on Monday.
The round also saw participation from Haibang Investment and Zheshang Venture Capital, a Hangzhou-based investment firm that has invested in fresh produce e-commerce platform MissFresh; ride-hailing player Caocao; and cloud video provider Arcvideo Tech, among others. ....

Sunshine Insurance Group Riverhead Capital Investment Management , Changxing Financial Holdings , Sealand Innovation , Matrix Partners , Sealand Securities , Haibang Investment , Zheshang Venture Capital , Arcvideo Tech , Wenzhou Investment , Haoyue Capital , Addor Capital , Sunshine Insurance Group , Riverhead Capital Investment Management , Shanghai Furong Investment , Biotrack Capital , Tengyuan Capital , Sequoia Capital China , Index Capital , Fortune Business , சீலண்ட் கண்டுபிடிப்பு , அணி கூட்டாளர்கள் , சீலண்ட் பத்திரங்கள் , சூரிய ஒளி காப்பீடு குழு , ரிவர்ஹெட் மூலதனம் முதலீடு மேலாண்மை , சீக்வோயா மூலதனம் சீனா , குறியீட்டு மூலதனம் ,